• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Quantitative bone evaluation to monitor in castration-resistant prostate cancer bone metastases

Research Project

Project/Area Number 18K07681
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 52040:Radiological sciences-related
Research InstitutionKagawa University

Principal Investigator

Tanaka kenichi  香川大学, 医学部附属病院, 助教 (10635824)

Co-Investigator(Kenkyū-buntansha) 杉元 幹史  香川大学, 医学部, 教授 (10243768)
久冨 信之  香川大学, 医学部, 准教授 (20552045)
山本 由佳  香川大学, 医学部, 准教授 (30335872)
西山 佳宏  香川大学, 医学部, 教授 (50263900)
則兼 敬志  香川大学, 医学部, 助教 (90623223)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords骨転移 / 前立腺癌 / 定量評価 / F-18 NaF / 骨シンチグラフィ / 去勢抵抗性前立腺癌 / 223Ra
Outline of Final Research Achievements

Both bone scintigraphy and 18F-NaF PET reflect osteoblastic activity, which is often increased in bone metastases of prostate cancer. Semiquantitative parameters, such as standardized uptake value (SUV), could be useful tools to evaluate biological activity at pathophysiological site. The bone uptake value (BUV), another semiquantitative index obtained from bone SPECT that indicates the degree of radioisotope accumulation, has been used to improve the diagnostic ability for detection of bone metastasis. The purpose of this study was to evaluate the usefulness of SPECT-BUV for assessment of bone metastases and to compare with PET-SUV. SPECT-BUV was significantly lower in bone metastases than PET-SUV. Significant correlation between SPECT-BUV and PET-SUV (P < 0.001) was found. The baseline burden of metastatic disease was demonstrated to be poor outcome. Baseline skeletal tumor burden as demonstrated on SPECT-BUV or PET-SUV may be a prognostic biomarker.

Academic Significance and Societal Importance of the Research Achievements

骨転移を評価する核医学画像診断として骨シンチグラフィと18F-NaF PETがある。PET検査の利点は視覚的評価に加え、定量評価が行えることである。骨転移の画像バイオマーカーとして18F-NaF PETを用いたSUVがある。骨シンチグラフィによるBUVは18F-NaF PETのSUVと相関を示し、有用な画像バイオマーカーの可能性が示された。前立腺癌の骨転移量を定量評価することで、病変の活動性や治療効果の評価に有用である可能性が示唆された。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (5 results)

All 2021 2020 2019 2018

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (4 results)

  • [Journal Article] The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 22021

    • Author(s)
      Naito Hirohito、Kato Takuma、Ishikawa Ryou、Tanaka Kenichi、Ueda Nobufumi、Matsuoka Yuki、Miyauchi Yasuyuki、Taoka Rikiya、Tsunemori Hiroyuki、Haba Reiji、Nishiyama Yoshihiro、Sugimoto Mikio、Kakehi Yoshiyuki
    • Journal Title

      Urology

      Volume: 149 Pages: 174-180

    • DOI

      10.1016/j.urology.2020.11.039

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Presentation] 前立腺癌骨転移における骨シンチグラフィとF-18 NaF PETによる比較2020

    • Author(s)
      田中賢一
    • Organizer
      香川県医学会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 前立腺癌骨転移におけるF-18 NaF PETとBone SPECTとの比較2019

    • Author(s)
      田中賢一
    • Organizer
      香川県核医学談話会
    • Related Report
      2019 Research-status Report
  • [Presentation] 去勢抵抗性前立腺癌に対するラジウム-223の初期使用経験2018

    • Author(s)
      田中賢一
    • Organizer
      香川県核医学談話会
    • Related Report
      2018 Research-status Report
  • [Presentation] 前立腺癌骨転移検索にBone SPECTとF-18 NaF PETを施行した症例2018

    • Author(s)
      田中賢一
    • Organizer
      日本核医学会中国・四国支部会
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi